drugset
drugset / Trial / NCT07357610

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

NCT07357610 ↗

Phase 1 Recruiting 60 enrolled Jiangsu Simcere Pharmaceutical Co., Ltd.
Non-randomizedSequentialOpen-labelOther

Summary

This study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.

Timeline

Start
2026-01-05
Primary completion
2026-10-30
Completion
2026-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject Midazolam Small molecule — Oral
Subject Rifampin Small molecule — Oral
Subject SIM0270 Unknown — Oral

Indications

No indication recorded.